{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:24Z","timestamp":1792593684227,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMMP110-01-02"],"award-info":[{"award-number":["TCMMP110-01-02"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-259-002-MY3"],"award-info":[{"award-number":["112-2314-B-259-002-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015576","name":"National Dong Hwa University","doi-asserted-by":"publisher","award":["114T2560-09"],"award-info":[{"award-number":["114T2560-09"]}],"id":[{"id":"10.13039\/100015576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07192-w","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:55:38Z","timestamp":1784901338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated transcriptomics reveals a TNFRSF-metabolism axis and a context-dependent BCMA signaling state in myeloma progression"],"prefix":"10.1007","volume":"105","author":[{"given":"Wei-Han","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Thangameeran Shaik","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1985-018X","authenticated-orcid":false,"given":"Chih-Wen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"1","key":"7192_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard F, Neri P, Bahlis NJ, Terpos E, Moukalled N, Hungria VTM, Manier S, Mohty M (2024) Multiple myeloma. Nat Rev Dis Primers 10(1):45. https:\/\/doi.org\/10.1038\/s41572-024-00529-7","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"7192_CR2","doi-asserted-by":"publisher","first-page":"189151","DOI":"10.1016\/j.bbcan.2024.189151","volume":"1879","author":"VG Varzieva","year":"2024","unstructured":"Varzieva VG, Mesonzhnik NV, Ilgisonis IS, Belenkov YN, Kozhevnikova MV, Appolonova SA (2024) Metabolomic biomarkers of multiple myeloma: A systematic review. Biochim Biophys Acta Rev Cancer 1879(5):189151. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189151","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7192_CR3","doi-asserted-by":"publisher","first-page":"1233383","DOI":"10.3389\/fcell.2023.1233383","volume":"11","author":"H Wong","year":"2023","unstructured":"Wong H, Sugimura R (2023) Immune-epigenetic crosstalk in haematological malignancies. Front Cell Dev Biol 11:1233383. https:\/\/doi.org\/10.3389\/fcell.2023.1233383","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"7192_CR4","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-23-3333","volume":"30","author":"CPM Verkleij","year":"2024","unstructured":"Verkleij CPM, O\u2019Neill CA, Broekmans MEC, Frerichs KA, Bruins WSC, Duetz C, Kruyswijk S, Baglio SR, Skerget S, Montes de Oca R, Zweegman S, Verona RI, Mutis T, van de Donk N (2024) T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. Clin Cancer Res 30(14):3006\u20133022. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-3333","journal-title":"Clin Cancer Res"},{"key":"7192_CR5","doi-asserted-by":"publisher","first-page":"1155621","DOI":"10.3389\/fonc.2023.1155621","volume":"13","author":"M Matamala Montoya","year":"2023","unstructured":"Matamala Montoya M, van Slobbe GJJ, Chang JC, Zaal EA, Berkers CR (2023) Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment. Front Oncol 13:1155621. https:\/\/doi.org\/10.3389\/fonc.2023.1155621","journal-title":"Front Oncol"},{"issue":"1","key":"7192_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40164-022-00303-z","volume":"11","author":"I Oudaert","year":"2022","unstructured":"Oudaert I, Van der Vreken A, Maes A, De Bruyne E, De Veirman K, Vanderkerken K, Menu E (2022) Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma. Exp Hematol Oncol 11(1):49. https:\/\/doi.org\/10.1186\/s40164-022-00303-z","journal-title":"Exp Hematol Oncol"},{"issue":"41","key":"7192_CR7","doi-asserted-by":"publisher","first-page":"43992","DOI":"10.18632\/oncotarget.6083","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, De Veirman K, De Beule N, Maes K, De Bruyne E, Van Valckenborgh E, Vanderkerken K, Menu E (2015) The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget 6(41):43992\u201344004. https:\/\/doi.org\/10.18632\/oncotarget.6083","journal-title":"Oncotarget"},{"issue":"7","key":"7192_CR8","doi-asserted-by":"publisher","first-page":"114445","DOI":"10.1016\/j.celrep.2024.114445","volume":"43","author":"P Peng","year":"2024","unstructured":"Peng P, Chavel C, Liu W, Carlson LM, Cao S, Utley A, Olejniczak SH, Lee KP (2024) Pro-survival signaling regulates lipophagy essential for multiple myeloma resistance to stress-induced death. Cell Rep 43(7):114445. https:\/\/doi.org\/10.1016\/j.celrep.2024.114445","journal-title":"Cell Rep"},{"key":"7192_CR9","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.neo.2024.100974","volume":"50","author":"X Zhou","year":"2024","unstructured":"Zhou X, He R, Hu WX, Luo S, Hu J (2024) Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors. Neoplasia 50:100974. https:\/\/doi.org\/10.1016\/j.neo.2024.100974","journal-title":"Neoplasia"},{"issue":"1","key":"7192_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41408-025-01284-y","volume":"15","author":"G Giorgetti","year":"2025","unstructured":"Giorgetti G, Maroto-Martin E, Soncini D, Fenoglio D, Becherini P, Benzi A, Ravera S, Traverso I, Ladisa F, Lai F, Rivoli G, Truffelli D, Nahimana A, Cagnetta A, Guolo F, Uras CRM, Schavgoulidze A, Fong Ng J, Nencioni A, Bruzzone S, Munshi NC, Lemoli RM, Fulciniti M, Cea M (2025) CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma. Blood Cancer J 15(1):83. https:\/\/doi.org\/10.1038\/s41408-025-01284-y","journal-title":"Blood Cancer J"},{"issue":"10","key":"7192_CR11","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1038\/bcj.2015.85","volume":"5","author":"C Ludwig","year":"2015","unstructured":"Ludwig C, Williams DS, Bartlett DB, Essex SJ, McNee G, Allwood JW, Jewell E, Barkhuisen A, Parry H, Anandram S, Nicolson P, Gardener C, Seymour F, Basu S, Dunn WB, Moss PA, Pratt G, Tennant DA (2015) Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma. Blood Cancer J 5(10):e359. https:\/\/doi.org\/10.1038\/bcj.2015.85","journal-title":"Blood Cancer J"},{"issue":"23","key":"7192_CR12","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1182\/blood-2016-09-692954","volume":"128","author":"MV Dhodapkar","year":"2016","unstructured":"Dhodapkar MV (2016) MGUS to myeloma: a mysterious gammopathy of underexplored significance. Blood 128(23):2599\u20132606. https:\/\/doi.org\/10.1182\/blood-2016-09-692954","journal-title":"Blood"},{"issue":"1","key":"7192_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12967-025-06637-6","volume":"23","author":"FE Ju","year":"2025","unstructured":"Ju FE, Huang BH, Wu H, Zou B, Chen SN, Sang XY, Liang WY, Liu ZX, Zhang ZX, Yang ZY, Liang YT, Liang YL, Liu H, Dong ZX, Liu XQ, Zheng LY, Zeng JC, Wang JH, Qi L, Zhang XD, Zheng Y, Li J (2025) Integrative analysis of bulk and single-cell gene expression profiles to identify bone marrow mesenchymal cell heterogeneity and prognostic significance in multiple myeloma. J Transl Med 23(1):659. https:\/\/doi.org\/10.1186\/s12967-025-06637-6","journal-title":"J Transl Med"},{"issue":"1","key":"7192_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40364-023-00502-8","volume":"11","author":"M Chen","year":"2023","unstructured":"Chen M, Jiang J, Hou J (2023) Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications. Biomark Res 11(1):55. https:\/\/doi.org\/10.1186\/s40364-023-00502-8","journal-title":"Biomark Res"},{"issue":"11","key":"7192_CR15","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1038\/s41375-021-01206-4","volume":"35","author":"HY Huang","year":"2021","unstructured":"Huang HY, Wang Y, Wang WD, Wei XL, Gale RP, Li JY, Zhang QY, Shu LL, Li L, Li J, Lin HX, Liang Y (2021) A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma. Leukemia 35(11):3212\u20133222. https:\/\/doi.org\/10.1038\/s41375-021-01206-4","journal-title":"Leukemia"},{"issue":"1","key":"7192_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li S, Wang D, Liu S, Xiao T, Gu W, Yang H, Wang H, Yang M, Chen P (2024) Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment. Biomark Res 12(1):96. https:\/\/doi.org\/10.1186\/s40364-024-00646-1","journal-title":"Biomark Res"},{"issue":"4","key":"7192_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s10555-024-10206-6","volume":"43","author":"O Ababneh","year":"2024","unstructured":"Ababneh O, Nishizaki D, Kato S, Kurzrock R (2024) Tumor necrosis factor superfamily signaling: life and death in cancer. Cancer Metastasis Rev 43(4):1137\u20131163. https:\/\/doi.org\/10.1007\/s10555-024-10206-6","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"7192_CR18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.immuni.2016.04.019","volume":"44","author":"LK Ward-Kavanagh","year":"2016","unstructured":"Ward-Kavanagh LK, Lin WW, Sedy JR, Ware CF (2016) The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses. Immunity 44(5):1005\u20131019. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.019","journal-title":"Immunity"},{"issue":"1","key":"7192_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-immunol-082423-040557","volume":"43","author":"TH Watts","year":"2025","unstructured":"Watts TH, Yeung KKM, Yu T, Lee S, Eshraghisamani R (2025) TNF\/TNFR Superfamily Members in Costimulation of T Cell Responses-Revisited. Annu Rev Immunol 43(1):113\u2013142. https:\/\/doi.org\/10.1146\/annurev-immunol-082423-040557","journal-title":"Annu Rev Immunol"},{"key":"7192_CR20","doi-asserted-by":"publisher","unstructured":"Bremer E (2013) Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy. ISRN Oncol 2013(371854). https:\/\/doi.org\/10.1155\/2013\/371854","DOI":"10.1155\/2013\/371854"},{"issue":"1","key":"7192_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1600-065X.2011.01067.x","volume":"244","author":"RC Rickert","year":"2011","unstructured":"Rickert RC, Jellusova J, Miletic AV (2011) Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 244(1):115\u2013133. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01067.x","journal-title":"Immunol Rev"},{"issue":"3","key":"7192_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.smim.2014.06.001","volume":"26","author":"WA Figgett","year":"2014","unstructured":"Figgett WA, Vincent FB, Saulep-Easton D, Mackay F (2014) Roles of ligands from the TNF superfamily in B cell development, function, and regulation. Semin Immunol 26(3):191\u2013202. https:\/\/doi.org\/10.1016\/j.smim.2014.06.001","journal-title":"Semin Immunol"},{"issue":"25","key":"7192_CR23","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1182\/blood-2016-01-691162","volume":"127","author":"YT Tai","year":"2016","unstructured":"Tai YT, Acharya C, An G, Moschetta M, Zhong MY, Feng X, Cea M, Cagnetta A, Wen K, van Eenennaam H, van Elsas A, Qiu L, Richardson P, Munshi N, Anderson KC (2016) APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment. Blood 127(25):3225\u20133236. https:\/\/doi.org\/10.1182\/blood-2016-01-691162","journal-title":"Blood"},{"key":"7192_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.exphem.2018.09.004","volume":"68","author":"SB Hay","year":"2018","unstructured":"Hay SB, Ferchen K, Chetal K, Grimes HL, Salomonis N (2018) The Human Cell Atlas bone marrow single-cell interactive web portal. Exp Hematol 68:51\u201361. https:\/\/doi.org\/10.1016\/j.exphem.2018.09.004","journal-title":"Exp Hematol"},{"key":"7192_CR25","doi-asserted-by":"publisher","unstructured":"Oetjen KA, Lindblad KE, Goswami M, Gui G, Dagur PK, Lai C, Dillon LW, McCoy JP, Hourigan CS (2018) Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry. JCI Insight 3(23). https:\/\/doi.org\/10.1172\/jci.insight.124928","DOI":"10.1172\/jci.insight.124928"},{"key":"7192_CR26","doi-asserted-by":"publisher","first-page":"1127879","DOI":"10.3389\/fimmu.2023.1127879","volume":"14","author":"NYS Lee","year":"2023","unstructured":"Lee NYS, Li M, Ang KS, Chen J (2023) Establishing a human bone marrow single cell reference atlas to study ageing and diseases. Front Immunol 14:1127879. https:\/\/doi.org\/10.3389\/fimmu.2023.1127879","journal-title":"Front Immunol"},{"issue":"D1","key":"7192_CR27","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, Chen J, Jiang W, Yang K, Ou Q, Li X, Wang P, Zhang Y (2023) CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res 51(D1):D870\u2013D876. https:\/\/doi.org\/10.1093\/nar\/gkac947","journal-title":"Nucleic Acids Res"},{"key":"7192_CR28","doi-asserted-by":"publisher","unstructured":"Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, Griesbeck M, Butler A, Zheng S, Lazo S, Jardine L, Dixon D, Stephenson E, Nilsson E, Grundberg I, McDonald D, Filby A, Li W, De Jager PL, Rozenblatt-Rosen O, Lane AA, Haniffa M, Regev A, Hacohen N (2017) Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356(6335). https:\/\/doi.org\/10.1126\/science.aah4573","DOI":"10.1126\/science.aah4573"},{"issue":"1","key":"7192_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q (2025) CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc 20(1):180\u2013219. https:\/\/doi.org\/10.1038\/s41596-024-01045-4","journal-title":"Nat Protoc"},{"issue":"3","key":"7192_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2567.2010.03306.x","volume":"131","author":"SM Lee","year":"2010","unstructured":"Lee SM, Jeon ST, Suk K, Lee WH (2010) Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals. Immunology 131(3):350\u2013356. https:\/\/doi.org\/10.1111\/j.1365-2567.2010.03306.x","journal-title":"Immunology"},{"issue":"5","key":"7192_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4110\/in.2010.10.5.173","volume":"10","author":"SM Lee","year":"2010","unstructured":"Lee SM, Kim WJ, Suk K, Lee WH (2010) Cell to Cell Interaction Can Activate Membrane-bound APRIL Which Are Expressed on Inflammatory Macrophages. Immune Netw 10(5):173\u2013180. https:\/\/doi.org\/10.4110\/in.2010.10.5.173","journal-title":"Immune Netw"},{"key":"7192_CR32","doi-asserted-by":"publisher","unstructured":"Zhang T, Ma C, Zhang Z, Zhang H, Hu H (2021) NF-kappaB signaling in inflammation and cancer. MedComm (2020) 2 (4):618\u2013653. https:\/\/doi.org\/10.1002\/mco2.104","DOI":"10.1002\/mco2.104"},{"key":"7192_CR33","doi-asserted-by":"publisher","unstructured":"Cippitelli M, Stabile H, Kosta A, Petillo S, Lucantonio L, Gismondi A, Santoni A, Fionda C (2023) Role of NF-kappaB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells. Int J Mol Sci 24(3). https:\/\/doi.org\/10.3390\/ijms24031823","DOI":"10.3390\/ijms24031823"},{"issue":"9","key":"7192_CR34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrc1974","volume":"6","author":"DM Sabatini","year":"2006","unstructured":"Sabatini DM (2006) mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6(9):729\u2013734. https:\/\/doi.org\/10.1038\/nrc1974","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"7192_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-020-00962-7","volume":"13","author":"B Yu","year":"2020","unstructured":"Yu B, Jiang T, Liu D (2020) BCMA-targeted immunotherapy for multiple myeloma. J Hematol Oncol 13(1):125. https:\/\/doi.org\/10.1186\/s13045-020-00962-7","journal-title":"J Hematol Oncol"},{"issue":"19","key":"7192_CR36","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1182\/blood.2019000050","volume":"134","author":"MJ Pont","year":"2019","unstructured":"Pont MJ, Hill T, Cole GO, Abbott JJ, Kelliher J, Salter AI, Hudecek M, Comstock ML, Rajan A, Patel BKR, Voutsinas JM, Wu Q, Liu L, Cowan AJ, Wood BL, Green DJ, Riddell SR (2019) gamma-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma. Blood 134(19):1585\u20131597. https:\/\/doi.org\/10.1182\/blood.2019000050","journal-title":"Blood"},{"issue":"25","key":"7192_CR37","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1182\/blood.2024026212","volume":"144","author":"H Lee","year":"2024","unstructured":"Lee H, Durante M, Skerget S, Vishwamitra D, Benaoudia S, Ahn S, Poorebrahim M, Barakat E, Jung D, Leblay N, Ziccheddu B, Diamond B, Papadimitriou M, Cohen AD, Landgren O, Neri P, Maura F, Bahlis NJ (2024) Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma. Blood 144(25):2637\u20132651. https:\/\/doi.org\/10.1182\/blood.2024026212","journal-title":"Blood"},{"issue":"7","key":"7192_CR38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1470-2045(23)00246-2","volume":"24","author":"AJ Cowan","year":"2023","unstructured":"Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN 3rd, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ (2023) gamma-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial. Lancet Oncol 24(7):811\u2013822. https:\/\/doi.org\/10.1016\/S1470-2045(23)00246-2","journal-title":"Lancet Oncol"},{"issue":"1","key":"7192_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40164-024-00535-1","volume":"13","author":"A Van der Vreken","year":"2024","unstructured":"Van der Vreken A, Vanderkerken K, De Bruyne E, De Veirman K, Breckpot K, Menu E (2024) Fueling CARs: metabolic strategies to enhance CAR T-cell therapy. Exp Hematol Oncol 13(1):66. https:\/\/doi.org\/10.1186\/s40164-024-00535-1","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"7192_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/17474086.2024.2370552","volume":"17","author":"K Zylka","year":"2024","unstructured":"Zylka K, Kubicki T, Gil L, Dytfeld D (2024) T-cell exhaustion in multiple myeloma. Expert Rev Hematol 17(7):295\u2013312. https:\/\/doi.org\/10.1080\/17474086.2024.2370552","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"7192_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41408-024-01172-x","volume":"14","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Sun F, Alapat DV, Wanchai V, Mery D, Siegel ER, Xu H, Johnson S, Guo W, Bailey C, Ashby C, Bauer MA, Hadidi SA, Schinke C, Thanendrarajan S, Zangari M, van Rhee F, Tricot G, Shaughnessy JD Jr., Zhan F (2024) Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages. Blood Cancer J 14(1):194. https:\/\/doi.org\/10.1038\/s41408-024-01172-x","journal-title":"Blood Cancer J"},{"issue":"1","key":"7192_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13045-016-0345-3","volume":"9","author":"C Zelle-Rieser","year":"2016","unstructured":"Zelle-Rieser C, Thangavadivel S, Biedermann R, Brunner A, Stoitzner P, Willenbacher E, Greil R, Johrer K (2016) T cells in multiple myeloma display features of exhaustion and senescence at the tumor site. J Hematol Oncol 9(1):116. https:\/\/doi.org\/10.1186\/s13045-016-0345-3","journal-title":"J Hematol Oncol"},{"key":"7192_CR43","doi-asserted-by":"publisher","unstructured":"Costa F, Marchica V, Storti P, Malavasi F, Giuliani N (2021) PD-L1\/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression. Cancers (Basel) 213. https:\/\/doi.org\/10.3390\/cancers13020164","DOI":"10.3390\/cancers13020164"},{"key":"7192_CR44","doi-asserted-by":"publisher","unstructured":"Roy P, Sarkar UA, Basak S (2018) The NF-kappaB Activating Pathways in Multiple Myeloma. Biomedicines 6(2). https:\/\/doi.org\/10.3390\/biomedicines6020059","DOI":"10.3390\/biomedicines6020059"},{"key":"7192_CR45","doi-asserted-by":"publisher","unstructured":"Damasceno D, Almeida J, Teodosio C, Sanoja-Flores L, Mayado A, Perez-Pons A, Puig N, Arana P, Paiva B, Solano F, Romero A, Matarraz S, van den Bossche WBL, Flores-Montero J, Durie B, van Dongen JJM, Orfao A (2021) Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. Cancers (Basel) 13(6). https:\/\/doi.org\/10.3390\/cancers13061454","DOI":"10.3390\/cancers13061454"},{"issue":"6","key":"7192_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41590-021-00931-3","volume":"22","author":"MME de Jong","year":"2021","unstructured":"de Jong MME, Kellermayer Z, Papazian N, Tahri S, Hofste Op Bruinink D, Hoogenboezem R, Sanders MA, van de Woestijne PC, Bos PK, Khandanpour C, Vermeulen J, Moreau P, van Duin M, Broijl A, Sonneveld P, Cupedo T (2021) The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nat Immunol 22(6):769\u2013780. https:\/\/doi.org\/10.1038\/s41590-021-00931-3","journal-title":"Nat Immunol"},{"issue":"4","key":"7192_CR47","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3324\/haematol.2016.150896","volume":"102","author":"M Ghermezi","year":"2017","unstructured":"Ghermezi M, Li M, Vardanyan S, Harutyunyan NM, Gottlieb J, Berenson A, Spektor TM, Andreu-Vieyra C, Petraki S, Sanchez E, Udd K, Wang CS, Swift RA, Chen H, Berenson JR (2017) Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients. Haematologica 102(4):785\u2013795. https:\/\/doi.org\/10.3324\/haematol.2016.150896","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07192-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07192-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07192-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:02:11Z","timestamp":1792591331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07192-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7192"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07192-w","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study analyzed publicly available de-identified human datasets and did not involve new participant recruitment, intervention, or collection of new human samples\/data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"469"}}